Illumina

YTD

ALL

Trade Illumina 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company was founded by David R.

CEO

Jacob Thaysen

CEOJacob Thaysen

Employees

8,600

Employees8,600

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1998

Founded1998

Employees

8,600

Employees8,600

ILMN Key Statistics

Market cap

33.57B

Market cap33.57B

Price-Earnings ratio

38.80

Price-Earnings ratio38.80

Dividend yield

—

Dividend yield—

Average volume

1.92M

Average volume1.92M

High today

$226.76

High today$226.76

Low today

$206.08

Low today$206.08

Open price

$208.95

Open price$208.95

Volume

3.15M

Volume3.15M

52 Week high

$231.81

52 Week high$231.81

52 Week low

$88.00

52 Week low$88.00

Stock Snapshot

With a market cap of 33.57B, Illumina(ILMN) trades at $224.00. The stock has a price-to-earnings ratio of 38.80.

As of 2026-09-15, Illumina(ILMN) stock has fluctuated between $206.08 and $226.76. The current price stands at $224.00, placing the stock +8.7% above today's low and -1.2% off the high.

Illumina(ILMN) shares are trading with a volume of 3.15M, against a daily average of 1.92M.

During the past year, Illumina(ILMN) stock moved between $88.00 at its lowest and $231.81 at its peak.

ILMN News

MarketWatch 6h

Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch

...

Nasdaq 6d

UBS Upgrades Illumina to Buy from Neutral

Fintel reports that on September 9, 2026, UBS upgraded their outlook for Illumina (NASDAQGS:ILMN) from Neutral to Buy. This upgrade follows a prior action by U...

Nasdaq 6d

Reasons to Retain Tandem Diabetes Stock in Your Portfolio Now

Tandem Diabetes Care, Inc. TNDM is well-positioned to grow in the coming quarters driven by the expanding product choices. The company’s pay-as-you-go reimburse...

Analyst ratings

50%

of 24 ratings

Buy

50%

Hold

33.3%

Sell

16.7%

More ILMN News

TipRanks 7d

Illumina assumed with a Buy at UBS

UBS assumed coverage of Illumina (ILMN) with a Buy rating and $260 price target Illumina stands out as a compelling revenue reacceleration and margin-expansion...

People also own

Based on the portfolios of people who own ILMN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.